Vulvovaginal Candidiasis Market Share, Demand and Industry Analysis Research Report by 2030
The market for Vulvovaginal Candidiasis (VVC) was valued at USD 971.51 million in 2021 and is anticipated to grow at a 4.2% CAGR in terms of revenue during the projected period. The rise in vulvovaginal candidiasis infections in women around the world, rising regulatory approvals for vulvovaginal candidiasis treatments, and an increase in clinical research studies into vulvovaginal candidiasis treatments are key factors propelling this market's revenue growth. The latest report is inclusive of an extensive coverage of the significant impact of the COVID-19 pandemic on the Vulvovaginal Candidiasis business sector. The coronavirus outbreak has drastically impacted the global economic landscape, and consequently, this particular business vertical. Therefore, the report provides the reader with a clear concept of the current scenario of this business vertical, estimating its COVID-19 aftereffects. Thus, the report encompasses the severe effects of the coronavirus pandemic on the Vulv...